Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...

The Israel-Iran clash seemingly has no end in sight — a prospect that does not seem to be panicking the markets.

Fat steers and heifers filled the pens at the Finney County Fairgrounds in the early morning hours of June 3, waiting to be ...

Company scales leadership to accelerate growth and reinforce market position as the leader in AI-powered life sciences procurement ...